Login / Signup
Glucagon in type 1 diabetes patients receiving SGLT2 inhibitors: A Friend or Foe?
Tomoyasu Fukui
Makoto Ohara
Sho-Ichi Yamagishi
Published in:
Diabetes/metabolism research and reviews (2020)
Keyphrases
</>
type diabetes
glycemic control
cardiovascular disease
insulin resistance
metabolic syndrome